Evidence map›Paper›PMID 38179195›Full record

ArticleRSC chemical biology2024

Increasing the functional density of threose nucleic acid.

Biju Majumdar, Daisy Sarma, Yutong Yu, Adriana Lozoya-Colinas, John C Chaput

Abstract read
In one paragraph

Article in RSC chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Biju MajumdarDepartment of Pharmaceutical Sciences, University of California Irvine CA 92697-3958 USA jchaput@uci.edu +1 949-824-8149.ORCID https://orcid.org/0000-0003-4041-2512
Daisy SarmaDepartment of Pharmaceutical Sciences, University of California Irvine CA 92697-3958 USA jchaput@uci.edu +1 949-824-8149.ORCID https://orcid.org/0000-0001-9264-0854
Yutong YuDepartment of Pharmaceutical Sciences, University of California Irvine CA 92697-3958 USA jchaput@uci.edu +1 949-824-8149.ORCID https://orcid.org/0009-0000-4656-9700
Adriana Lozoya-ColinasDepartment of Pharmaceutical Sciences, University of California Irvine CA 92697-3958 USA jchaput@uci.edu +1 949-824-8149.ORCID https://orcid.org/0000-0001-8217-0596
John C ChaputDepartment of Pharmaceutical Sciences, University of California Irvine CA 92697-3958 USA jchaput@uci.edu +1 949-824-8149.ORCID https://orcid.org/0000-0003-1393-135X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical strategies that augment genetic polymers with amino acid residues that are overrepresented on the paratope surface of an antibody offer a promising route for enhancing the binding properties of nucleic acid aptamers. Here, we describe the chemical synthesis of α-l-threofuranosyl cytidine nucleoside triphosphate (tCTP) carrying either a benzyl or phenylpropyl side chain at the pyrimidine C-5 position. Polymerase recognition studies indicate that both substrates are readily incorporated into a full-length α-l-threofuranosyl nucleic acid (TNA) product by extension of a DNA primer-template duplex with an engineered TNA polymerase. Similar primer extension reactions performed using nucleoside triphosphate mixtures containing both C-5 modified tCTP and C-5 modified tUTP substrates enable the production of doubly modified TNA strands for a panel of 20 chemotype combinations. Kinetic measurements reveal faster on-rates (

Identifiers

PMID38179195
PMCPMC10763562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.